Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 55 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Seelos Therapeutics Inc | SEEL | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.3271 | 07:13:27 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.3271 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 3 | 55 | - | 0.3201 - 49.80 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 06:58:08 | 11 | $ 0.3299 | USD |
Seelos Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.51M | 13.68M | - | 2.2M | -37.88M | -2.77 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Seelos Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SEEL Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.3979 | 0.3979 | 0.3201 | 0.3315698 | 375,360 | -0.0708 | -17.79% |
| 1 Month | 0.524 | 0.68 | 0.3201 | 0.476813 | 402,759 | -0.1969 | -37.58% |
| 3 Months | 1.06 | 1.36 | 0.3201 | 0.7378322 | 436,846 | -0.7329 | -69.14% |
| 6 Months | 6.291 | 6.63 | 0.3201 | 3.37 | 1,451,149 | -5.96 | -94.80% |
| 1 Year | 20.265 | 49.80 | 0.3201 | 9.68 | 2,039,110 | -19.94 | -98.39% |
| 3 Years | 190.80 | 198.00 | 0.3201 | 44.65 | 2,005,475 | -190.47 | -99.83% |
| 5 Years | 95.10 | 198.00 | 0.3201 | 73.34 | 2,292,483 | -94.77 | -99.66% |
Seelos Therapeutics Description
| Seelos Therapeutics Inc is a clinical-stage biotechnology company. The company is focused on developing products that address significant unmet needs in the Central Nervous System (CNS) disorders and other rare disorders. |
